Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Pharmacological Reports : PR|February 21, 2014
Possible contribution of IGF-1 to depressive disorderEwa Szczęsny, Joanna Slusarczyk, Katarzyna Głombik, et al.
Psychoneuroendocrinology|April 9, 2008
Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acidTomasz Schneider, Adam Roman, Agnieszka Basta-Kaim, et al.
Polish Journal of Pharmacology|July 18, 2003
Effect of antidepressant drugs on the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cellsBogusława Budziszewska, Lucylla Jaworska-Feil, Magdalena Tetich, et al.
Neuropharmacology|July 6, 2005
Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathwayAgnieszka Basta-Kaim, Bogusława Budziszewska, Lucylla Jaworska-Feil, et al.
European Journal of Pharmacology|July 14, 2004
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cellsAgnieszka Basta-Kaim, Bogusława Budziszewska, Lucylla Jaworska-Feil, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 22, 2004
Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cellsBogusława Budziszewska, Lucylla Jaworska-Feil, Magdalena Tetich, et al.
European Journal of Pharmacology|November 2, 2010
Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: effects of antipsychotic drugsAgnieszka Basta-Kaim, Bogusława Budziszewska, Monika Leśkiewicz, et al.
Pageof 12